IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 77 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 474,609 | $626,000 | 0.55% |
| Kassirer Asset Management Corp | 325,800 | $430,000 | 0.28% |
| CORRADO ADVISORS, LLC | 104,850 | $138,000 | 0.08% |
| Artal Group S.A. | 2,750,000 | $3,630,000 | 0.08% |
| ROPES WEALTH ADVISORS LLC | 100,000 | $132,000 | 0.04% |
| MYCIO WEALTH PARTNERS, LLC | 246,527 | $325,000 | 0.03% |
| Palo Alto Investors LP | 616,355 | $814,000 | 0.03% |
| HOLLENCREST CAPITAL MANAGEMENT | 172,570 | $228,000 | 0.03% |
| LAU ASSOCIATES LLC | 26,713 | $35,000 | 0.02% |
| NATIXIS | 3,438,529 | $4,539,000 | 0.02% |